Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses.

Spencer S, Köstel Bal S, Egner W, Lango Allen H, Raza SI, Ma CA, Gürel M, Zhang Y, Sun G, Sabroe RA, Greene D, Rae W, Shahin T, Kania K, Ardy RC, Thian M, Staples E, Pecchia-Bekkum A, Worrall WPM, Stephens J, Brown M, Tuna S, York M, Shackley F, Kerrin D, Sargur R, Condliffe A, Tipu HN, Kuehn HS, Rosenzweig SD, Turro E, Tavaré S, Thrasher AJ, Jodrell DI, Smith KGC, Boztug K, Milner JD, Thaventhiran JED.

J Exp Med. 2019 Jun 24. pii: jem.20190344. doi: 10.1084/jem.20190344. [Epub ahead of print]

PMID:
31235509
2.

Recommendation to include hydroxyethyl (meth)acrylate in the British baseline patch test series.

Rolls S, Chowdhury MM, Cooper S, Cousen P, Flynn AM, Ghaffar SA, Green CM, Haworth A, Holden C, Johnston GA, Naidoo K, Orton DI, Reckling C, Sabroe RA, Scorer M, Stone NM, Thompson D, Wakelin S, Wilkinson M, Buckley DA.

Br J Dermatol. 2019 Jan 31. doi: 10.1111/bjd.17708. [Epub ahead of print]

PMID:
30703264
3.

Recommendation to test limonene hydroperoxides 0·3% and linalool hydroperoxides 1·0% in the British baseline patch test series.

Wlodek C, Penfold CM, Bourke JF, Chowdhury MMU, Cooper SM, Ghaffar S, Green C, Holden CR, Johnston GA, Mughal AA, Reckling C, Sabroe RA, Stone NM, Thompson D, Wilkinson SM, Buckley DA.

Br J Dermatol. 2017 Dec;177(6):1708-1715. doi: 10.1111/bjd.15648. Epub 2017 Nov 16.

PMID:
28494107
4.

Has the epidemic of allergic contact dermatitis due to methylisothiazolinone reached its peak?

Venables ZC, Bourke JF, Buckley DA, Campbell F, Chowdhury MMU, Abdul-Ghaffar S, Green C, Holden CR, McFadden J, Orton D, Sabroe RA, Sansom J, Stone NM, Wakelin SH, Wilkinson SM, Johnston GA.

Br J Dermatol. 2017 Jul;177(1):276-278. doi: 10.1111/bjd.15016. Epub 2017 May 29. No abstract available.

PMID:
27579576
5.

Mutations in POGLUT1 in Galli-Galli/Dowling-Degos disease.

Wilson NJ, Cole C, Kroboth K, Hunter WN, Mann JA, McLean WH, Kernland Lang K, Beltraminelli H, Sabroe RA, Tiffin N, Sobey GJ, Borradori L, Simpson E, Smith FJ.

Br J Dermatol. 2017 Jan;176(1):270-274. doi: 10.1111/bjd.14914. Epub 2016 Sep 24. No abstract available.

6.

Contact allergy to essential oils cannot always be predicted from allergy to fragrance markers in the baseline series.

Sabroe RA, Holden CR, Gawkrodger DJ.

Contact Dermatitis. 2016 Apr;74(4):236-41. doi: 10.1111/cod.12528. Epub 2016 Jan 25.

PMID:
26806578
7.

Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.

Sabroe RA.

Br J Dermatol. 2014 Jul;171(1):13-5. doi: 10.1111/bjd.13074. No abstract available.

PMID:
25066289
8.

Acute urticaria.

Sabroe RA.

Immunol Allergy Clin North Am. 2014 Feb;34(1):11-21. doi: 10.1016/j.iac.2013.07.010. Epub 2013 Aug 24. Review.

PMID:
24262686
9.

Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra.

Sabroe RA, Stokes CA, Parker LC, Higgins K, Prince LR, Sabroe I.

Clin Exp Dermatol. 2013 Dec;38(8):874-7. doi: 10.1111/ced.12186. Epub 2013 Jul 25.

PMID:
23889084
10.

Roles of neutrophils in the regulation of the extent of human inflammation through delivery of IL-1 and clearance of chemokines.

Basran A, Jabeen M, Bingle L, Stokes CA, Dockrell DH, Whyte MK, Walmsley SR, Higgins KR, Vogel SN, Wilson HL, Prince LR, Prestwich EC, Sabroe RA, Parker LC, Sabroe I.

J Leukoc Biol. 2013 Jan;93(1):7-19. doi: 10.1189/jlb.0512250. Epub 2012 Aug 17.

11.

Failure of omalizumab in cholinergic urticaria.

Sabroe RA.

Clin Exp Dermatol. 2010 Jun;35(4):e127-9. doi: 10.1111/j.1365-2230.2009.03748.x. Epub 2009 Nov 19.

PMID:
19925484
12.

EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria.

Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE.

Allergy. 2009 Sep;64(9):1256-68. doi: 10.1111/j.1398-9995.2009.02132.x. Epub 2009 Jul 24. Review.

PMID:
19650847
13.

Chronic idiopathic urticaria with functional autoantibodies: 12 years on.

Sabroe RA, Greaves MW.

Br J Dermatol. 2006 May;154(5):813-9. Review.

PMID:
16634880
14.

Chronic urticaria: aetiology, management and current and future treatment options.

Kozel MM, Sabroe RA.

Drugs. 2004;64(22):2515-36. Review.

PMID:
15516152
15.

Twice-daily vs. once-daily inpatient dithranol for psoriasis.

Kirkup ME, Sabroe RA, Kavanagh GM, Downs AM, Sansom JE, de Berker DA, Dunnill MG, Kennedy CT, Archer CB.

Clin Exp Dermatol. 2002 Nov;27(8):695-9.

PMID:
12472549
16.

Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity.

Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE, Black AK, Stingl G, Greaves MW, Barr RM.

J Allergy Clin Immunol. 2002 Sep;110(3):492-9.

PMID:
12209101
17.

Lymphocytic infiltrates as a presenting feature of Sweet's syndrome with myelodysplasia and response to cyclophosphamide.

Evans AV, Sabroe RA, Liddell K, Russell-Jones R.

Br J Dermatol. 2002 Jun;146(6):1087-90.

PMID:
12072085
18.

Chronic urticaria.

Grattan CE, Sabroe RA, Greaves MW.

J Am Acad Dermatol. 2002 May;46(5):645-57; quiz 657-60. Review.

PMID:
12004303
19.

An audit of the use of self-administered adrenaline syringes in patients with angio-oedema.

Sabroe RA, Glendinning AK, Sabroe I, Lawlor F, Kobza Black A.

Br J Dermatol. 2002 Apr;146(4):615-20.

PMID:
11966692
20.

Methotrexate-responsive chronic idiopathic urticaria: a report of two cases.

Gach JE, Sabroe RA, Greaves MW, Black AK.

Br J Dermatol. 2001 Aug;145(2):340-3. Review.

PMID:
11531806
21.

Schnitzler's syndrome: no evidence for autoimmune basis in two patients.

Gallo R, Sabroe RA, Black AK, Greaves MW.

Clin Exp Dermatol. 2000 Jun;25(4):281-4.

PMID:
10971485
22.

Rituximab in cutaneous B-cell lymphoma: a report of two cases.

Sabroe RA, Child FJ, Woolford AJ, Spittle MF, Russell-Jones R.

Br J Dermatol. 2000 Jul;143(1):157-61.

PMID:
10886152
23.

Erythema elevatum diutinum/Sweet's syndrome overlap with gastrointestinal and oral involvement.

Evans AV, Sabroe RA, Setterfield J, Greaves MW.

Br J Dermatol. 1999 Oct;141(4):766-7. No abstract available.

PMID:
10583147
24.

The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria.

Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW.

Br J Dermatol. 1999 Mar;140(3):446-52.

PMID:
10233264
25.

Scombrotoxic fish poisoning.

Sabroe RA, Kobza Black A.

Clin Exp Dermatol. 1998 Nov;23(6):258-9.

PMID:
10233620
26.

Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies.

Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW.

J Am Acad Dermatol. 1999 Mar;40(3):443-50.

PMID:
10071316
27.

Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies.

Sabroe RA, Poon E, Orchard GE, Lane D, Francis DM, Barr RM, Black MM, Black AK, Greaves MW.

J Allergy Clin Immunol. 1999 Mar;103(3 Pt 1):484-93.

PMID:
10069884
28.

Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.

Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW.

J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):651-8.

PMID:
9802375
29.

The intradermal effects of the H3 receptor agonist R alpha methylhistamine in human skin.

Kavanagh GM, Sabroe RA, Greaves MW, Archer CB.

Br J Dermatol. 1998 Apr;138(4):622-6.

PMID:
9640366
30.

ABC of allergies. Allergy and the skin. I--Urticaria.

Greaves MW, Sabroe RA.

BMJ. 1998 Apr 11;316(7138):1147-50. Review. No abstract available.

31.

The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.

Sabroe RA, Kennedy CT, Archer CB.

Br J Dermatol. 1997 Sep;137(3):386-90.

PMID:
9349334
32.

The pathogenesis of chronic idiopathic urticaria.

Sabroe RA, Greaves MW.

Arch Dermatol. 1997 Aug;133(8):1003-8. Review.

PMID:
9267248
33.

Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema.

Sabroe RA, Black AK.

Br J Dermatol. 1997 Feb;136(2):153-8. Review.

PMID:
9068723
34.

Histamine: the quintessential mediator.

Greaves MW, Sabroe RA.

J Dermatol. 1996 Nov;23(11):735-40. Review.

PMID:
8990694
35.

Minocycline-induced discolouration of the sclerae.

Sabroe RA, Archer CB, Harlow D, Bradfield JW, Peachey RD.

Br J Dermatol. 1996 Aug;135(2):314-6.

PMID:
8881683
36.

Urticarial vasculitis associated with polycythaemia rubra vera.

Farell AM, Sabroe RA, Bunker CB.

Clin Exp Dermatol. 1996 Jul;21(4):302-4.

PMID:
8959906
37.

Agminate Spitz naevi occurring in an adult after the excision of a solitary Spitz naevus--report of a case and review of the literature.

Sabroe RA, Vaingankar NV, Rigby HS, Peachey RD.

Clin Exp Dermatol. 1996 May;21(3):197-200. Review.

PMID:
8914359
38.

Contact allergy to gold sodium thiosulfate.

Sabroe RA, Sharp LA, Peachey RD.

Contact Dermatitis. 1996 May;34(5):345-8.

PMID:
8807228
39.

Bronchospasm induced by isotretinoin.

Sabroe RA, Staughton RC, Bunker CB.

BMJ. 1996 Apr 6;312(7035):886. No abstract available.

40.

Facial granulomatous lymphoedema and syringomyelia.

Sabroe RA, Kennedy CT.

Clin Exp Dermatol. 1996 Jan;21(1):72-4.

PMID:
8689778
41.

Dermatomyositis treated with high-dose intravenous immunoglobulins and associated with panniculitis.

Sabroe RA, Wallington TB, Kennedy CT.

Clin Exp Dermatol. 1995 Mar;20(2):164-7. Review.

PMID:
8565257
42.

Polymyositis and malignant melanoma.

Sabroe RA, Dorman P, Harlow D, Ormerod IE, Kennedy CT.

Br J Dermatol. 1995 Feb;132(2):312-3. No abstract available.

PMID:
7888375
43.

Multiple lentigines confined to psoriatic plaques.

Burrows NP, Handfield-Jones S, Monk BE, Sabroe RA, Geraghty JM, Norris PG.

Clin Exp Dermatol. 1994 Sep;19(5):380-2.

PMID:
7955492

Supplemental Content

Loading ...
Support Center